Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 31.93 Billion | USD 87.14 Billion | 11.8% | 2023 |
The global precision medicine market size was worth around USD 31.93 billion in 2023 and is predicted to grow to around USD 87.14 billion by 2032 with a compound annual growth rate (CAGR) of roughly 11.8% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The report covers a forecast and an analysis of the Precision Medicine market on a global and regional level.
Precision medication (PM) is a form of medication that uses data about a person’s genes, proteins, lifestyle, and environment to forestall, diagnose, and treat diseases. It is an emerging approach that proposes the customization of aid with medical alternatives, treatments, practices, or merchandise that are being tailored for an individual patient.
Modern developments in applications of big data technologies for the correct detection of diseases are driving the precision drugs market. In addition, important company players are concentrating their efforts on improving software systems that support drug discovery procedures, which, in turn, helps in storing huge amounts of genetic information, thereby supporting the medicine precision market. However, deviation from treatment-based to preventive healthcare, abstaining trends in food and drug administration pharmacotherapy approval rate, the encroachment of privacy rules, and misconception of genetic and health data may limit the precision medicine market growth.
The study contributes a conclusive view of the precision medicine market by segmenting the market based on technology, application, end-user, and region.
By technology, the market is divided into drug discovery, big data analytics, bioinformatics, companion diagnostics, genomic sequencing, and others. The drug discovery segment holds the largest market share, of about 25%, which is closely followed by companion diagnostics and genomic sequencing.
Based on application, the market includes respiratory, oncology, CNS, immunology, and others. Oncology is likely to witness the highest CAGR in the market over the forecast timeframe. Immunology accounted for the second-largest market share in 2023 and is anticipated to indicate similar growth trends over the forthcoming years.
By end-user, the market includes pharmacy and biotechnology firms, diagnostic companies, healthcare-IT/big data firms, clinical laboratories, and others. Healthcare-IT/big data firms are predicted to hold a substantial share in the precision medicine market over the estimated timeframe.
Report Attributes | Report Details |
---|---|
Report Name | Precision Medicine Market |
Market Size in 2023 | USD 31.93 Billion |
Market Forecast in 2032 | USD 87.14 Billion |
Growth Rate | CAGR of 11.8% |
Number of Pages | 110 |
Key Companies Covered | Eagle Genomics, Biocrates Life Sciences, Teva Pharmaceuticals, Novartis, Quest Diagnostics, Qiagen, Silicon Biosystems, NanoString Technologies, Ferrer inCode, Laboratory Corporation of America Holdings, Pfizer, Hoffmann-La Roche, and Tepnel Pharma Services |
Segments Covered | By technology, By application, By end-user and By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America is likely to account for the most important share of the precision medicine market over the forecast timeframe, owing to the increasing geriatric population suffering from chronic diseases like cancer, cardiovascular diseases, diabetes, etc. The Asia Pacific precision medicine market is projected to grow notably in the future, owing to the rising burden of genetic diseases in China that will drive the demand for gene therapies. Government of China has taken initiatives to fund the Chinese precision medicine market growth, which will advance the Asia Pacific precision medicine market growth in the future.
Some major players of the precision medicine market are:
Precision Medicine Market: By Technology
Precision Medicine Market: By Application
Precision Medicine Market: By End-User
Precision Medicine Market: By Region
FrequentlyAsked Questions
Precision medicine, also known as personalized medicine, is a medical approach that tailors diagnosis, treatment, and prevention strategies to individual patients based on their unique genetic, environmental, and lifestyle factors.
According to study, the Precision Medicine market size was worth around USD 31.93 billion in 2023 and is predicted to grow to around USD 87.14 billion by 2032.
The CAGR value of Precision Medicine market is expected to be around 11.8% during 2024-2032.
North America has been leading the Precision Medicine market and is anticipated to continue on the dominant position in the years to come.
The Precision Medicine market is led by players like Eagle Genomics, Biocrates Life Sciences, Teva Pharmaceuticals, Novartis, Quest Diagnostics, Qiagen, Silicon Biosystems, NanoString Technologies, Ferrer inCode, Laboratory Corporation of America Holdings, Pfizer, Hoffmann-La Roche, and Tepnel Pharma Services.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed